MedTrials

MedTrials

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

MedTrials is a US-based, privately-held contract research organization (CRO) with a 20-year track record of delivering clinical trial services. The company operates as a full-service CRO, offering end-to-end solutions from study design and site management to data informatics, compliance, and therapeutic-specific consulting. Its strategic focus is on aligning the 'art and science' of clinical research, leveraging integrated technology solutions and deep expertise in specialized therapeutic areas like ophthalmology and dermatology to ensure reliable, timely, and cost-effective trial execution for pharmaceutical, biotechnology, and medical device sponsors.

OphthalmologyDermatologyCardiologyGastroenterology

Technology Platform

Integrated technology solutions for data management and sponsor advantage, utilizing customized tools and automation rather than a single proprietary platform.

Opportunities

Growth in outsourced clinical trials, especially in niche therapeutic areas like ophthalmology and dermatology where MedTrials has deep expertise.
Increasing demand for integrated data management and technology solutions in clinical research presents an opportunity to expand service offerings and client value.

Risk Factors

High competition in the CRO market from large global players and niche firms.
Dependency on the R&D spending cycles of biopharma and medical device sponsors, which can be volatile.
Operational risks related to trial execution, data quality, and regulatory compliance.

Competitive Landscape

MedTrials competes in the fragmented CRO market, facing competition from large, full-service global CROs (e.g., IQVIA, ICON) and smaller, specialized CROs. Its differentiation is based on therapeutic expertise (particularly ophthalmology), a full-service offering, and a 20-year track record of 'sustained performance'.